Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Cognitieve therapie helpt patiënten met myotone dystrofie type 1
okt 2018 | Neuro-musculair